Report Overview

Global Autoinjectors Market- Industry Trends & Forecast Report 2027

Global autoinjectors market was worth USD 44.3 billion in 2020 and is further projected to reach USD 120.2 billion by 2027, at a CAGR of 15.4% during the forecast period (2021-2027). The integration of technology with medical devices and an increasing number of targeted therapies worldwide drive the growth for autoinjectors market. Since cancer patients commonly use targeted treatments, the demand has grown as the global prevalence of cancer has increased. According to WHO, there will be 30.2 million cancer cases worldwide by 2040. In addition, the rising number of anaphylactic shock cases among anaphylaxis patients is boosting the industry.

Source: BlueWeave Consulting

Global Autoinjectors Overview

A syringe with a preloaded dose of medication and a spring-loaded needle are considered as autoinjectors. When the device is pressed against the body in a stabbing motion, it activates and administers a calculated dose of medication. Autoinjectors are widely used by migraine sufferers to self-administer epinephrine (to avoid anaphylaxis) and by military and emergency service personnel to counteract the effects of nerve agents. Autoinjectors have a number of advantages, including reducing the risk of needle-related phobia disorder, decreasing the risk of needle-stick injuries, maintaining dose quality accuracy, and increasing efficacy.

Global Autoinjectors Market Trend

Growth Drivers

Increasing Number of Technological Advancements

Technological advancements in the field of healthcare has positively impacted the market. Nowadays, auto-injectors are preferred over conventional devices as they enable efficient and improved drug delivery as well as new formulations. Technological advancements in products are also anticipated to boost growth for the market. Collaboration with top academic institutions and engineering companies to create innovatively advanced autoinjectors for patients who need them most is a key component of creating a good Research & Development (R&D) company that drives the market growth. For instance in April 2021, Teva Pharmaceutical Industries Ltd., announced the launch and availability of a new autoinjector for AJOVY. People who are suffering from four migrane days in a month can use AJOVY. It is a subcutaneous medication used to avoid migraine attacks in adults. It was only available in prefilled syringes when it was first introduced in 2020, but now AJOVY is available in two formats: autoinjectors and prefilled syringes.

Growing Prevalence of Targeted Therapies

Targeted therapy is a type of cancer treatment in which specific proteins and genes are targeted using specified drugs that are involved in cancer cell growth and survival. Targeted therapy can alter the tissue environment that promotes cancer growth and survival, or it can target cancer-related cells like blood vessel cells. Doctors nowadays frequently combine targeted therapy with chemotherapy and other treatments. The Food and Drug Administration (FDA) of the United States has also approved targeted therapies for a variety of cancers. Autoinjectors are used to kill particular cells in the body for this targeted therapy.

According to The World Health Organization, in 2020, there were 19.3 million cancer cases. The number of cases is expected to reach 30.2 million by 2040. Men are more likely to develop lung, prostate, colorectal, stomach, and liver cancers, while women are more likely to develop breast, colorectal, lung, cervical, and thyroid cancers. The market is also expected to benefit from the rising demand for successful targeted therapies procedures for cancer.

Restraints

Alternative Drug Delivery Model

The majority of patients experience pain and find it inconvenient to administer medication through syringes or other conventional methods. Since autoinjectors may be painful in some cases, new or alternative drug delivery models are used to treat the condition. Nasal, oral, and topical drug delivery are examples of alternative drug delivery models. These alternative drug delivery models are low-cost, reliable, and widely embraced by patients due to their convenience. According to a 2019 study published in the Journal of Advanced Study, most children are afraid of needles, with 20-50 % of adolescents and 20-30% of adults having this fear. As previously reported, the fear of needles and the adoption of new drug delivery models are limiting the market growth for autoinjectors.

Impact of COVID-19

COVID-19 has had a negative impact on the supply chain in a variety of industries. When the economies of various countries were reviving, some of them were hit by the second wave of the COVID-19 pandemic. COVID-19 has wreaked havoc on countries such as India and Brazil. The deadly virus has had an impact on several industries, including automotive, chemical, oil and gas, pharmaceuticals, construction and building, and others. However, some sectors of the pharmaceutical industry are growing. As the autoinjectors market has grown significantly in the year 2020, most of the patients found it challenging to go to the hospital in the fear of contracting the virus. Furthermore, as technology advances, patients are finding it more convenient to use autoinjectors at home.

Global Autoinjectors Market: By Type

Based on type, the global autoinjectors market is grouped into disposable and reusable. In 2020, the disposable segment accounted for the largest share in the autoinjectors market by applications segment. Patients are increasingly using disposable autoinjectors because they are cost-effective, easy to use, have built-in glass syringes, and are convenient. Furthermore, disposable autoinjectors contribute to less disease spread. In addition, the rising advancement for biodegradable disposable autoinjectors further drives the market for autoinjectors market.

1.    Research Framework

1.1. Research Objective

1.2. Product Overview

1.3. Market Segmentation

2.    Research Methodology

2.1. Qualitative Research

2.1.1.   Primary & Secondary Research

2.2. Quantitative Research

2.3. Market Breakdown & Data Triangulation

2.3.1.   Secondary Research

2.3.2.   Primary Research

2.4. Breakdown of Primary Research Respondents, By Region

2.5. Assumption & Limitation

3.    Executive Summary

4.    Global Autoinjectors Market Insights

4.1. Industry Value Chain Analysis

4.2. DROC Analysis

4.2.1.   Growth Drivers

4.2.2.   Restraints

4.2.3.   Opportunities

4.2.4.   Challenges

4.3. Recent Development

4.4. Government Regulations

4.5. Porter’s Five Forces Analysis

4.5.1.   Bargaining Power of Suppliers

4.5.2.   Bargaining Power of Buyers

4.5.3.   Threat of New Entrants

4.5.4.   Threat of Substitutes

4.5.5.   Intensity of Rivalry

5.    Global Autoinjectors Market Overview

5.1. Market Size & Forecast by Value, 2017-2027

5.1.1.   By Value (USD Million)

5.2. Market Share & Forecast

5.2.1.   By Type

5.2.1.1.       Disposable

5.2.1.2.       Reusable

5.2.2.   By Therapy

5.2.2.1.       Rheumatoid Arthritis

5.2.2.2.       Diabetes

5.2.2.3.       Multiple Sclerosis

5.2.2.4.       Anaphylaxis

5.2.2.5.       Other Therapies

5.2.3.   By Route of Administration

5.2.3.1.       Subcutaneous

5.2.3.2.       Intramuscular

5.2.4.   By End-Users

5.2.4.1.       Homecare

5.2.4.2.       Hospitals & Clinics

5.2.4.3.       Ambulatory Care Settings

5.2.5.   By Region

5.2.5.1.     North America

5.2.5.2.     Europe

5.2.5.3.     Asia Pacific

5.2.5.4.     Latin America

5.2.5.5.     Middle East and Africa

6.    North America Autoinjectors Market  

6.1. Market Size & Forecast by Value, 2017-2027

6.1.1.   By Value (USD Million)

6.2. Market Share & Forecast

6.2.1.   By Type

6.2.2.   By Therapy

6.2.3.   By Route of Administration

6.2.4.   By End-Users

6.2.5.   By Country

6.2.5.1.     U.S.

6.2.5.2.     Canada

7.    Europe Autoinjectors Market

7.1. Market Size & Forecast by Value, 2017-2027

7.1.1.   By Value (USD Million)

7.2. Market Share & Forecast

7.2.1.   By Type

7.2.2.   By Therapy

7.2.3.   By Route of Administration

7.2.4.   By End-Users

7.2.5.   By Country

7.2.5.1.     Germany

7.2.5.2.     United Kingdom

7.2.5.3.     Italy

7.2.5.4.     France

7.2.5.5.     Spain

7.2.5.6.     Rest of Europe

8.    Asia Pacific Autoinjectors Market

8.1. Market Size & Forecast by Value, 2017-2027

8.1.1.   By Value (USD Million)

8.2. Market Share & Forecast

8.2.1.   By Type

8.2.2.   By Therapy

8.2.3.   By Route of Administration

8.2.4.   By End-Users

8.2.5.   By Country

8.2.5.1.     China

8.2.5.2.     India

8.2.5.3.     Japan

8.2.5.4.     Australia

8.2.5.5.     South Korea

8.2.5.6.     Rest of Asia Pacific

9.    Latin America Autoinjectors Market

9.1.  Market Size & Forecast by Value, 2017-2027

9.1.1.       By Value (USD Million)

9.2. Market Share & Forecast

9.2.1.       By Type

9.2.2.       By Therapy

9.2.3.       By Route of Administration

9.2.4.       By End-Users

9.2.5.       By Country

9.2.5.1.     Brazil

9.2.5.2.     Mexico

9.2.5.3.     Argentina

9.2.5.4.     Rest of Latin America

10.Middle East & Africa Autoinjectors Market

10.1. Market Size & Forecast by Value, 2017-2027

10.1.1.  By Value (USD Million)

10.2. Market Share & Forecast

10.2.1.    By Type

10.2.2.    By Therapy

10.2.3.    By Route of Administration

10.2.4.    By End-Users

10.2.5.    By Country

10.2.5.1.  Saudi Arabia

10.2.5.2.  Turkey

10.2.5.3.  UAE

10.2.5.4.  South Africa

10.2.5.5.  Rest of Middle East & Africa

11.Competitive Landscape

11.1.          List of Key Players and Their Offerings

11.2.          Market Share Analysis, 2020

11.3.          Competitive Benchmarking, By Operating Parameters

12.Impact of Covid-19 on Autoinjectors Market Industry

13.Company Profile (Company Overview, Financial Matrix, Competitive landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook)

13.1.        AbbVie Inc.

13.2.        Mylan

13.3.        Eli Lilly and Company

13.4.        Ypsomed

13.5.        Amgen

13.6.        Becton, Dickinson and Company

13.7.        GlaxoSmithKline plc

13.8.        Johnson & Johnson

13.9.        Teva Pharmaceutical

13.10.     Antares Pharma

13.11.     Merck KGaA

13.12.     Other Prominent Players

14.Key Strategic Recommendations

List of Figures

Fig: Global Autoinjectors Segmentation

Fig: Global Autoinjectors Market Value Chain Analysis

Fig: Company Market Share Analysis, 2020

Fig: Global Autoinjectors Market Size, By Value (USD Million), 2017-2027

Fig: Global Autoinjectors Market Share, By Type, By Value, 2017-2027

Fig: Global Autoinjectors Market Share, By Therapy, By Value, 2017-2027

Fig: Global Autoinjectors Market Share, By Route of Administration, By Value, 2017-2027

Fig: Global Autoinjectors Market Share, By End-Users, By Value, 2017-2027

Fig: Global Autoinjectors Market Share, By Region, By Value, 2017-2027

Fig: North America Autoinjectors Market Size, By Value (USD Million), 2017-2027

Fig: North America Autoinjectors Market Share, By Type, By Value, 2017-2027

Fig: North America Autoinjectors Market Share, By Therapy, By Value, 2017-2027

Fig: North America Gowns Market Share, By Route of Administration, By Value, 2017-2027

Fig: North America Autoinjectors Market Share, By End-Users, By Value, 2017-2027

Fig: North America Autoinjectors Market Share, By Country, By Value, 2017-2027

Fig: Europe Autoinjectors Market Size, By Value (USD Million), 2017-2027

Fig: Europe Autoinjectors Market Share, By Type, By Value, 2017-2027

Fig: Europe Autoinjectors Market Share, By Therapy, By Value, 2017-2027

Fig: Europe Autoinjectors Market Share, By Route of Administration, By Value, 2017-2027

Fig: Europe Autoinjectors Market Share, By End-Users, By Value, 2017-2027

Fig: Europe Autoinjectors Market Share, By Country, By Value, 2017-2027

Fig: Asia-Pacific Autoinjectors Market Size, By Value (USD Million), 2017-2027

Fig: Asia-Pacific Autoinjectors Market Share, By Type, By Value, 2017-2027

Fig: Asia-Pacific Autoinjectors Market Share, By Therapy, By Value, 2017-2027

Fig: Asia-Pacific Autoinjectors Market Share, By Route of Administration, By Value, 2017-2027

Fig: Asia-Pacific Autoinjectors Market Share, By End-Users, By Value, 2017-2027

Fig: Asia-Pacific Autoinjectors Market Share, By Country, By Value, 2017-2027

Fig: Latin America Autoinjectors Market Size, By Value (USD Million), 2017-2027

Fig: Latin America Autoinjectors Market Share, By Type, By Value, 2017-2027

Fig: Latin America Autoinjectors Market Share, By Therapy, By Value, 2017-2027

Fig: Latin America Autoinjectors Market Share, By Route of Administration, By Value, 2017-2027

Fig: Latin America Autoinjectors Market Share, By End-Users, By Value, 2017-2027

Fig: Latin America Autoinjectors Market Share, By Country, By Value, 2017-2027

Fig: Middle East & Africa Autoinjectors Market Size, By Value (USD Million), 2017-2027

Fig: Middle East & Africa Autoinjectors Market Share, By Type, By Value, 2017-2027

Fig: Middle East & Africa Autoinjectors Market Share, By Therapy, By Value, 2017-2027

Fig: Middle East & Africa Autoinjectors Market Share, By Route of Administration, By Value, 2017-2027

Fig: Middle East & Africa Autoinjectors Market Share, By End-Users, By Value, 2017-2027

Fig: Middle East & Africa Autoinjectors Market Share, By Country, By Value, 2017-2027

List of Table

Table: Global Autoinjectors Market Size, By Type, By Value, 2017-2027

Table: Global Autoinjectors Market Size, By Therapy, By Value, 2017-2027

Table: Global Autoinjectors Market Size, By Route of Administration, By Value, 2017-2027

Table: Global Autoinjectors Market Size, By End-Users, By Value, 2017-2027

Table: Global Autoinjectors Market Size, By Region, By Value, 2017-2027

Table: North America Autoinjectors Market Size, By Type, By Value, 2017-2027

Table: North America Autoinjectors Market Size, By Therapy, By Value, 2017-2027

Table: North America Autoinjectors Market Size, By Route of Administration, By Value, 2017-2027

Table: North America Autoinjectors Market Size, By End-Users, By Value, 2017-2027

Table: North America Autoinjectors Market Size, By Country, By Value, 2017-2027

Table: Europe Autoinjectors Market Size, By Type, By Value, 2017-2027

Table: Europe Autoinjectors Market Size, By Therapy, By Value, 2017-2027

Table: Europe Autoinjectors Market Size, By Route of Administration, By Value, 2017-2027

Table: Europe Autoinjectors Market Size, By End-Users, By Value, 2017-2027

Table: Europe Autoinjectors Market Size, By Country, By Value, 2017-2027

Table: Asia-Pacific Autoinjectors Market Size, By Type, By Value, 2017-2027

Table: Asia-Pacific Autoinjectors Market Size, By Therapy, By Value, 2017-2027

Table: Asia-Pacific Autoinjectors Market Size, By Route of Administration, By Value, 2017-2027

Table: Asia-Pacific Autoinjectors Market Size, By End-Users, By Value, 2017-2027

Table: Asia-Pacific Autoinjectors Market Size, By Country, By Value, 2017-2027

Table: Latin America Autoinjectors Market Size, By Type, By Value, 2017-2027

Table: Latin America Autoinjectors Market Size, By Therapy, By Value, 2017-2027

Table: Latin America Autoinjectors Market Size, By Route of Administration, By Value, 2017-2027

Table: Latin America Autoinjectors Market Size, By End-Users, By Value, 2017-2027

Table: Latin America Autoinjectors Market Size, By Country, By Value, 2017-2027

Table: Middle East & Africa Autoinjectors Market Size, By Type, By Value, 2017-2027

Table: Middle East & Africa Autoinjectors Market Size, By Therapy, By Value, 2017-2027

Table: Middle East & Africa Autoinjectors Market Size, By Route of Administration, By Value, 2017-2027

Table: Middle East & Africa Autoinjectors Market Size, By End-Users, By Value, 2017-2027

Table: Middle East & Africa Autoinjectors Market Size, By Country, By Value, 2017-2027

Table: AbbVie Inc. Inc Financial Analysis

Table: Mylan Financial Analysis

Table: Eli Lilly and Company Financial Analysis

Table: Ypsomed Financial Analysis

Table: Becton, Dickinson and Company Financial Analysis

Table: Miltenyi Biotec Financial Analysis

Table: Charles River Laboratories Financial Analysis

Table: GlaxoSmithKline plc Financial Analysis

Table: Johnson & Johnson Financial Analysis

Table: Teva Pharmaceutical Financial Analysis

Table: Antares Pharma Financial Analysis

Table: Merck KGaA Financial Analysis